TNF and medulloblastoma: Systemic administration of RGD4C.TPA.TNFα to mice‐bearing subcutaneous medulloblastoma xenografts resulted in selective tumor homing of these particles and consequently, targeted tumor expression of TNFα, apoptosis, and destruction of the tumor vasculature.